|Study Participants||Healthcare Professionals||Researchers||Locations||Publications||What is TrialNet?||News and Events||Get Screened!||Home|
Information for Researchers
Information for Research Collaborators
Call for Proposals
Type 1 Diabetes TrialNet is soliciting applications to use samples from TrialNet protocols using oral insulin to identify biomarkers that can determine whether oral insulin has an immunological effect and to help explore dose and dosing regimen.
Letter of Intent due February 12, 2016.
The Living Biobank initiative provides researches with on-demand access to subjects at risk for the development of type 1 diabetes. Exploratory research is welcome.
Ancillary studies that complement the objectives of TrialNet studies are strongly encouraged. Researchers can submit proposals for access to archived samples, subjects seen at a single center (for access to subjects seen at multiple centers, see Living Biobank above), or subject data. Learn More >
The National Institute of Diabetes and Digestive Disease (NIDDK) Central Data Repository (CDR) is a web-enabled resource available to researchers and the general public. The CDR warehouses clinical data and study documentation from NIDDK funded research, including such landmark studies as the Diabetes Prevention Trial Type 1 (DPT-1, the forerunner of TrialNet), The Diabetes Control and Complications Trial (DCCT, 1983-93) and the Epidemiology of Diabetes Interventions and Complications (EDIC, 1994-present) follow-up study which has been ongoing for more than 20 years. The CDR also houses data from over 7 million biospecimens representing 2 million subjects.
Samples and data are available by application at www.niddkrepository.org.
For additional information, please refer to the TrialNet Sample and Data Sharing Policy
Other Funding Opportunities in type 1 Diabetes